A Dyadic Intervention for Young Adult Patients With Cancer and Their Partner Caregivers
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age25-39
SponsorMassachusetts General Hospital
About this trial
The purpose of this pilot study is to examine the feasibility and acceptability of a brief psychotherapy intervention to improve psychosocial coping and maintain couple relationships among young adults (aged 25-39) with cancer and their caregiving partners.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Either: (1) Currently receiving active cancer treatment (n=5) or are within two years of completing active treatment (n=5) at Massachusetts General Cancer Center (MGHCC), located in Boston, Massachusetts, United States, OR (2) are the partner of an individual between the ages of 25-39 who is currently receiving treatment at MGHCC (n=5) or who has completed cancer treatment at MGHCC within the past two years (n=5)
Either: (1) Indicates a score ≥4 on the National Comprehensive Cancer Network (NCCN) adapted distress thermometer study screening questions, OR (2) are the partner of a participant indicating a score ≥4 on the NCCN adapted distress thermometer study screening questions
English-speaking
Disqualifiers
None
Trial design
Design model
Single group
Treatments tested in this trial
Young Adults Coping with Cancer Together Intervention
BehavioralThis intervention is based on cognitive-behavioral therapy and couples' therapy. It aims to improve cancer and caregiving-related self-efficacy and coping, as well as promote relationship maintenance in context of cancer. The intervention will be delivered by a trained mental health practitioner and include didactics, experiential exercises, and home practice.
Treatment groups
20 Participants
are divided into 1 treatment groupGroup A: Young Adults Coping with Cancer Together InterventionOther 1 intervention
Trial outcomes
Primary outcomes
1
Feasibility of Intervention
Feasibility will be measured by measured by participant rates of enrollment (≥50% of those eligible), participant retention (≥70% of those enrolled), and intervention attendance (≥70% attending at least 6 of 8 sessions).
Time frame
14 +/- 2 Weeks2
Acceptability of Intervention
Acceptability with be measured by satisfaction with the intervention as rated on the Client Satisfaction Questionnaire. The intervention will be deemed acceptable if ≥75% of participants report average satisfaction that exceeds the CSQ's midpoint.
Time frame
14 +/- 2 WeeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov